Els W. M. van Etten

Biodistribution of liposomal amphotericin B (AmBisome) and amphotericin B-desoxycholate (Fungizone) in uninfected immunocompetent mice and leucopenic mice infected with <i>Candida albicans</i>

Els W. M. van Etten, Marièe Otte-Lambillion, Wim van Vianen et al. · Journal of Antimicrobial Chemotherapy · 1995 · 88 citations

Immunotoxicology, Fungal Cell Biology, Immunology +18

Efficacies of amphotericin B-desoxycholate (Fungizone), liposomal amphotericin B (AmBisome) and fluconazole in the treatment of systemic candidosis in immunocompetent and leucopenic mice

Els W. M. van Etten, Cora van den Heuvel-de Groot, Irma A. J. M. Bakker‐Woudenberg · Journal of Antimicrobial Chemotherapy · 1993 · 71 citations

Administration of Liposomal Agents and Blood Clearance Capacity of the Mononuclear Phagocyte System

Els W. M. van Etten, Marian T. ten Kate, Susan V. Snijders et al. · Antimicrobial Agents and Chemotherapy · 1998 · 51 citations · Full text

Aerosol Delivery of Amphotericin B Desoxycholate (Fungizone) and Liposomal Amphotericin B (AmBisome): Aerosol Characteristics and In-vivo Amphotericin B Deposition in Rats

Elisabeth J. Ruijgrok, Arnold G. Vulto, Els W. M. van Etten · Journal of Pharmacy and Pharmacology · 2000 · 50 citations · Full text

Asthma, Pharmaceutical Science, Immunology +17

Nebulization of four commercially available amphotericin B formulations in persistently granulocytopenic rats with invasive pulmonary aspergillosis: evidence for long-term biological activity

Elisabeth J. Ruijgrok, Marcel H.A.M. Fens, Irma A. J. M. Bakker‐Woudenberg et al. · Journal of Pharmacy and Pharmacology · 2005 · 42 citations